pH-responsive selenium nanoplatform for targeted drug release and immune remodeling in microbiota-associated colorectal cancer
{{output}}
Fusobacterium nucleatum (F. nucleatum) is implicated in colorectal cancer (CRC) initiation, progression, and resistance to therapy, while conventional antibiotics show poor specificity and disrupt intestinal homeostasis. Here, we present a dual bacteria-tumor ... ...
